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Purpose: To evaluate Myt272 protein antigenicity and immunogenicity by trial vaccination in mice and 
its in silico analysis as a potential peptide vaccine for tuberculosis.  
Methods: Myt272 gene, which has 100 % identity with Mycobacterium tuberculosis H37Rv unknown 
function gene Rv3424c, was ligated by genomic shotgun approach into the expression vector pQE32, 
and transformed into Escherichia coli SG13009. Expression during cell growth was induced by 
isopropyl-β-D-thiogalactopyranoside. The recombinant protein was isolated from the harvested cell 
lysate and injected in mice for immunogenicity experiment up to 42 days. ELISA tests with anti-His 
antibodies were performed on the collected individual blood samples’ sera. Color development in a 
microplate reader was measured at 450 nm. 
Results: The protein was predicted to have a mass of approximately 13 kDa and was present in the 
soluble fraction of the cell lysate. The immunogenicity test on Myt272 protein revealed very statistically 
significant high levels of antibodies detected by ELISA in the sera of immunized group of mice 
compared to negative controls.  
Conclusion: A 10.1 kD unnamed function (IDALA) protein from Rv3424 gene could be the potential 
peptide vaccine for tuberculosis tested by mice immunogenicity experiment. 
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INTRODUCTION 
 
Tuberculosis (TB) ranks second only to 
human immunodeficiency virus as the 
greatest killer worldwide due to a single 
infectious agent. In 2010, there were 8.8 
million incidents of TB globally, 1.1 million 
deaths from TB among HIV-negative people 
and an additional 0.35 million deaths from 
HIV-associated TB. About 13 % of TB cases 
occur among people living with HIV, 
indicating a strong correlation between these 
two deadly diseases [1]. Mycobacterium 
bovis bacillus Calmette-Guérin (BCG) is the 
current vaccine administered against TB 
worldwide. However, doubts about its efficacy 
are increasing, reflected by its highly variable 
protective efficacy in controlled clinical trials. 
A number of reasons have been suggested 
for the variation of BCG efficacy, including 
genetic variability, differences in the age of 
vaccinated individuals and immunological 
cross reactivity between BCG and 
environmental mycobacterial strains 
prevalent in different parts of the world [2].  
 
Besides the live attenuated and DNA 
vaccines, peptide vaccine has seen an 
explosive increase in the development as a 
potential new tuberculosis vaccine candidate 
[3]. Two recombinant BCG vaccines stably 
expressing and secreting the 30-kDa 
secreted protein of Mycobacterium 
tuberculosis (Mtb) have been shown to 
induce greater protective immunity against 
tuberculosis than conventional BCG vaccines 
in a highly susceptible animal model [4]. The 
ESAT-6 from the culture filtrate, a 6-kD 
secreted protein of Mtb has been a candidate 
vaccine antigen for many years [5]. A 338 
amino acid synthetic peptide vaccine from 
Mtb was reported to be important in the 
binding ability to major histocompatibility 
complex (MHC) class I & II molecules for 
vaccine development [6]. This is the first 
systematic nucleotide-protein bioinformatic 
analysis study involving immunogenicity 
experiment for the purpose of discovering a 




Cloning and expression of Myt272 DNA 
insert containing Rv3424c gene  
 
Mycobacterium tuberculosis H37Rv 
genomic DNA was partially digested with 
Sau3A1, generating restriction fragments 
that were subsequently inserted at the unique 
BamHI site in the vector plasmid pUC18 
using genomic shotgun cloning. Myt272 
was one of the 13 Myt clones that 
showed the highest lethality of 12 hours 
in Balb/c mice using 1mL intra-
peritoneal injections containing 103 CFU 
whole cell bacteria. The DNA insert of 
Myt272 containing Rv3424c gene was 
constructed from M. tuberculosis H37Rv 
genome via shotgun cloning and established 
in E. coli  before sub-cloning in the bacterial 
expression vector pQE32 (Qiagen, Hilden, 
Germany) in frame with an N-terminal six-
histidine tag via Sma 1 and Pst 1 restriction 
enzymes. Myt272 DNA insert was then 
released via restriction enzymes Sma1 and 
Pst1 and the band was extracted from 
electrophoretic gel by QIA quick gel 
extraction kit (Qiagen, Germany). The 
purified DNA insert of Myt272 was analyzed 
on 1.2% agarose gel alongside with DNA 
mass ruler (Fermentas, Canada) prior to 
subcloning into an expression system, 
pQE32, in order to study the protein. 
 
Characterization and purification of 
recombinant protein Myt272 
 
A trace of E. coli cells SG13009 (pREP4) 
(Qiagen, Germany) was streaked out on LB 
agar containing the appropriate antibiotic 
kanamycin (25 µg/mL) and then incubated at 
37 °C overnight. A single colony was picked 
and inoculated in 10 ml of LB medium 
containing kanamycin and the functional 
bacteria cells were prepared as described 
previously [8]. Double digested pQE32 (200 
ng) was then mixed with 150 ng (6 µL) of 
double digested insert Myt272. 2 µL of ligase 
and 2 µL ligase buffer were added and the 
reaction was adjusted to 20 µL with sterile 
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H2O before the mixture was incubated 
overnight at 4 °C [8]. Positive and negative 
controls for the transformation of competent 
cells were carried out as described previously 
[Error! Bookmark not defined.]. 
Transformants of correct insert were detected 
by screening bacterial colonies via miniprep 
plasmid extraction (Qiagen, Germany). The 
growth inducing, expression and purification 
of E. coli were done by following the 
manufacturer's instructions (Qiagen, 
Germany). The induced cell pellet were 
thawed on ice for 15 min and resuspended in 
10 mL native lysis buffer prior to incubation 
on ice for 30 min. The cell suspension was 
mixed 2–3 times by gentle swirling. The 
lysate was centrifuged at 14,000 rpm for 30 
min at 4°C to pellet the cellular debris. The 
cell lysate supernatant containing the soluble 
fraction of the recombinant protein was 
retained for further purification using the Fast 
Start Column and used for the 
immunogenicity tests of the recombinant 
protein Myt272. Purification of expressed 
protein for SDS-PAGE was conducted under 
native and denaturing conditions as 
described previously [9-10]. The separation 
of the 6xHis-tagged protein with respect to 
ruler protein ladder (Fermentas, Canada) by 
SDS-PAGE was carried out as described 
[11].  
 
Immunization and antibody response in 
mice   
 
Six weeks old pathogen-free Balb/c mice 
weighing about 25 g were used for the 
immunization experiment. The mice were 
randomly divided into two groups (10 
mice/group) and they were deprived of food 
intake 3 h prior to immunization. The first 
group of mice was immunized with 
recombinant protein emulsified with an equal 
volume of Ribi adjuvant, while the other 
groups were used as controls (Ribi adjuvant 
only, Myt272 recombinant protein only and 
saline only). To determine the 
immunogenicity of the recombinant 
protein, the 10 Balb/c mice were 
immunized at three occasions (2-week 
intervals) with 100 µg protein/mouse/ 
injection subcutaneously. Blood samples 
were collected from mice on 0, 14, 28 
and 42 days post-immunization. At the 
end of immunization schedule the 
vaccinated mice and control mice were 
sacrificed in conformity with ethical rules 
[12] approved by the Laboratory Animal 
Centre, University of Malaya (approval 
ref no. PM/03/11/2008/0511/SI (R)). 
Peripheral blood from the tails of the mice 
was collected. ELISA tests with anti-His 
antibodies [13] were performed on the sera 
samples. Penta His antibodies (Qiagen, 
Germany) were diluted in coating buffer 50 
mM (sodium carbonate, pH 10.6) to a final 
concentration of 3 μg/mL, then 200 μL of 
diluted antibody were loaded into wells of a 
96-well microplate. After soaking and 
washing for 4 times, the wells of the dry plate 
were coated with 200 μl of secondary 
antibodies (anti-Human IgG) (Qiagen., 
Germany) conjugated to horseradish 
peroxidase which were diluted in PBS/BSA 
(1:500) [14-15]. The color development in a 
microplate reader was monitored for 45 min. 
50 μL of stop reagent (2M H2SO4) were 
added before the product was measured at 
450 nm. A control without protein and a 
reagent blank containing only the detection 
reagent were run together in the same assay. 
All protein concentrations were determined 




ELISA data analysis from at least three 
independent experiments was performed 
using GraphPad QuickCalcs software. 
Independent sample unpaired T-test with 
p < 0.05 was considered significant. Unpaired 
T-test was conducted to compare the IgG 
level for immunized and control mice after 42 
days. The data were expressed as 
mean ± standard deviations (SD) and mice 
antibody response curve was plotted with 
standard error bars using Microsoft Excel 
2007.  
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Analysis of the Myt272 DNA and protein 
sequences 
 
The clone Myt272 was successfully 
sequenced with automated DNA sequencer 
for pQE32 vector system with forward primer 
5' CGGATAACAATTTCACACAG 3' and 
reverse primer 3' GGTCATTACTGGAGTCT 
TG 5'. The Myt272 sequence was then blast 
with nucleotide blast, blastn [16] to search for 
identical region(s) against the H37Rv 
complete genomic database. The amino acid 
sequences were obtained using the ExPASy 
translate tool (http://web.expasy.org/tran 
slate/) and blast for identical proteins using 
translated blast (tblastx) and standard protein 




Characterization of Myt272 recombinant 
protein from Rv3424c gene 
 
Double digestion for Myt272 in pUC18 vector 
by Sma1 and Pst1 enzymes shows the 2.7 
kbp pUC18 vector and the insert Myt272 as a 
448 bp band on an agarose gel (Fig 1). The 
insert size is similar to the size stated after 
shotgun cloning and library construction for 




Fig 1:  Agarose gel electrophoresis confirming the 
Myt272 DNA insert size using Sma1 and Pst1 
restriction enzymes. Lane 1 =  1 kb DNA ladder; 
Lane 2 =  Digested recombinant clone 
pUC18/Myt272  
                    
The insert Myt272 was successfully sub-
cloned into pQE32 vector based on the T5 
promoter transcription-translation system. 
The produced clone size was found to be 3.8 
kbp on agarose gel (Fig 2a) by using 
supercoiled ladder marker. Restriction 
endonuclease double digestion of the 
subclone by pQE32 using enzyme Sma1 and 
Pst l confirmed the 0.448 kbp Myt272 and the 
3.4 kbp pQE32 vector in agarose gel (Fig 2b). 





Lane 1-2 = Recombinant clone pQE32/Myt272;   





Lane 1 = 1kb DNA ladder; Lane 2 = Recombinant 
clone pQE32/Myt272 
 
Fig 2:  (a) Electrophoresis gel showing the 
pQE32/Myt272 recombinant plasmids of 3.8 kb 
and the 7.6 kb dimer; (b) Agarose gel 
electrophoresis shows the double digested 
plasmid from recombinant clone pQE32/Myt272 
confirming the 448 bp DNA insert.  
b) 
     1   2           
     3 kbp 
     1.5 kbp 
     500 bp 
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The 448 nucleotide sequences of the 
insert Myt272 in FASTA format are shown 
in Fig 3. The sub-cloning of Myt272 to 
pQE32 vector should provide a high level 
expression of 6xHis-tagged proteins in E. 
coli. Unfortunately, the 6xHis-tagged Myt272 
protein was partially purified in this study due 
to poor SDS-PAGE gel resolution and 
determined to be approximately 13 kDa 
under native condition. There was no protein 
band detected under denaturing condition 
indicating that the recombinant protein 



















Fig 3: Nucleotide sequence of Myt272 DNA 
fragment (448 bp) derived from M. 
tuberculosis H37Rv genome.  
  
High titers of IgG antibodies were detected in 
the sera of mice immunized with the Myt272 
protein antigen emulsified in Ribi adjuvant, 
whereas for controls Ribi adjuvant only, 
Myt272 recombinant protein only and saline 
only, the titers of IgG were low. In immunized 
mice sera, the amount of antibodies was 40 
times higher than that of controls for the 
duration of 12 days to 28 days (Fig 4). 
Myt272 protein antigen emulsified in Ribi 
adjuvant shows an extremely statistically 
significant difference in IgG level compared to 
the control groups with p < 0.05 (p = 0.0001). 
The difference in mean equals 0.6043 and 
the 95% confidence interval of this difference 
is from 0.5197 to 0.6889. We noted that as 
the OD450nm of all three control groups were 
0.01  0.02  0.01, the ODs were pooled 
together as one control group and was 
compared to Myt272 immunized group for the 
T-test. 
 
Fig 4: Antibody response to the Myt272 
recombinant protein and controls in vaccinated 
mice. 
 Key:  ♦ = Myt272 emulsified in Ribi adjuvant; ∆ = 
Myt272 only; Ribi adjuvant only; saline only; (OD450nm = 
0.010.02  0.01)   
 
Proposed potential novel peptide vaccine 
candidate using in silico approach 
 
The nucleotide blast (blastn) resulted in 
100% identity of the Myt272 DNA (1-336) to 
M. tuberculosis complete genome H37Rv, 
segment 12/13 (AC: BX842583.1) (24428-
24763). In addition, blastn also produced a 
similar region with 96% identity of 1-336 DNA 
sequence of Myt272 with 29354-29689 
region of complete genome of H37Rv. The 
blastn also showed that the transposase and 
PPE family region of complete genome of 
H37Rv were not overlapping but flanking the 
Myt272 DNA sequences. 99% identity of 4-
336 Myt272 DNA sequences with 117-448 
region of reverse sequence of M. bovis BCG 
Pasteur deleted region RD6 was obtained. 
Myt272 DNA sequences were translated into 
six reading frames but only two important 
frames are shown in Fig 5. They are the 5'3' 
frame 3 and 3'5' frames 3 with four and three 
peptides, respectively. Short peptides (< 10 
amino acids) were not considered in the 
analysis. The longest peptide consists of 94 
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amino acids from 3'5' frame 3, fragment B 
showed 100% identity in protein-protein blast 
(74 amino acid coverage for alignment) with 
the H37Rv unnamed protein product started 
with “I D A L A……”.  
 
5'3' Frame 3 
  A 
Stop [R S L T A A H H P W Q E T V A V C T I R P 
R L P Q F R G K] Stop [T Y C A R A S L H G Y G 
L W R 
   B 
S L R T I N A D S A D S A N R R H T P C T D V G 
C F] Stop [D G A K V G V S F I F T T P Q A L D N 
A A 
 C (35 a.a)      
K S V S G I H D L W R K G R] Stop [G I D L  
D (40 a.a) 
S L A D L G V S S R D A V V L S G E L S E L L G 
R T V S P I D F W E H P] 
 
3'5' Frame 3 
  A        
B (94 a.a) 
[R V L P E V N R R Y G P A Q Q L] Stop [Q F A G 
Q Y D R V A G A D A E V G K R Q  
I D A L A S F A P Q I V N P R H G L S R V V Q C 
L G G C E N K R H A Y F R S I S K T P H I R A R 
G V P S V C A V R T V G  
C 
V D G A K R P P K P I P V Q] Stop [C T G A I G S 
L P P E L R Q S R A N S T H C N C F L P R V 
Met G R G Q A T L X] 
  
Fig 5: The amino acid sequences translated from 
Myt272 DNA sequences. IDALA protein is 
highlighted in grey; a.a = amino acid 
 
5'3' frame 3 showed 100 % identity (38/40 
aligned)  of fragment D to ppsA gene product 
in M. tuberculosis H37Rv and 96% identity 
(25/35 aligned) of fragment C to low quality 
protein for PE family protein in M. 
tuberculosis T46 but a lower identity of 53% 
(15/35 aligned) with PE family protein from M. 
tuberculosis H37Rv. The computed molecular 
weight for ppsA gene product and PE family 
protein were 4.3 and 3.7 kD, respectively. 
The ppsA gene product and PE family protein 
are not novel as they have been reported in 
previous studies [17-18]. Less important 5'3' 
frame 2 and 3'5' frame 2 fragments showed 
100% identity to M. bovis BCG Pasteur 
deleted region RD6 by the translated blast 
(tblastx). However, this result is not 
conclusive as the alignment is based the 
antisense strand of M bovis BCG Pasteur 
strain and the amino acid sequences contain 
several termination amino acids. All other 
fragments showed no significant similarity in 
protein-protein blast or showed identities with 





In this study, genomic shotgun cloning was 
performed to produce a highly virulent clone, 
Myt272 for tuberculosis from the 
Mycobacterium tuberculosis strain H37Rv 
genome. The toxicity of Myt272 clone was 
evident in mice lethality within 12 hours using 
1mL intra-peritoneal injections containing as 
low as 103 CFU whole cell bacteria. The 
virulent gene fragment that was ligated in 
pUC18 and sub-clone pQE32 vectors was 
then analyzed by 1.2% agarose gel. The 
results showed that the insert has a size of 
448 bp from the double digestion of these two 
vectors as shown in Fig 1 and Fig 2, 
respectively. The insert was successfully 
sequenced to reveal the nucleotide 
sequences and the nucleotide blast (blastn) 
showed that 1-336 bp of the insert was 
identical to a gene fragment in M. 
tuberculosis strain H37Rv genome. The 
remaining 337-448 nucleotide sequences 
matched with a non-contiguous gene 
fragment in M. tuberculosis strain H37Rv 
genome most probably due to the random 
assembly of gene fragments by genomic 
shotgun cloning approach [19].  
 
The nucleotide sequences for Myt272 were 
then translated into six reading frames. 
Protein blast results indicated that the longest 
peptide which consists of 94 amino acids 
from 3'5' frame 3, fragment B (Fig 5) was 
named as IDALA protein due to its 100% 
alignment identity (74 amino acids coverage 
within 1-336 bp nucleotide region) with 
H37Rv unnamed protein and it could be the 
possible candidate peptide for vaccine 
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development. This is because the molecular 
weight of IDALA protein computed as 10.1 kD 
using the Expasy tools is comparable to the 
partially purified Myt272 recombinant protein 
with a molecular weight of around 13 kD 
determined in this study by SDS-PAGE 
(SDS-PAGE result not shown due to poor gel 
resolution). The protein blast also showed 
that IDALA protein was coded by the gene 
Rv3424c from Mycobacterium tuberculosis 
strain H37Rv. In addition, the molecular 
weight of IDALA protein is also within the size 
of potential peptide vaccine ranges from 6 to 
30 kD as reported previously [Error! 
Bookmark not defined., Error! Bookmark 
not defined.]. The molecular weight for 
Rv3424c gene product was recorded as 13.0 
kD at TB database 
(http://tuberculist.epfl.ch/quicksearch.php?ge
ne+name=Rv3424c&submit=Search).   
 
Although the nucleotide sequences can be 
translated into six reading frames of amino 
acid sequences with numerous peptides, 
IDALA protein was predicted as the target 
immunogenic protein because it contains the 
longest amino acid sequences of 94 amino 
acids. In general, a protein consists of at 
least 100 amino acids may be considered as 
a functional protein [20]. In addition, IDALA 
protein is an unnamed protein with unknown 
function compared to ppsA gene product and 
PE protein (found in other reading frame) 
which were already well reported. After 
thorough amino acid sequence analysis of six 
translated reading frames, IDALA protein was 
selected as the target protein based on the 
highest amino acid percentage coverage for 
sequence alignment and highest percentage 
identity in sequence alignment.  
 
In the mice immunogenicity experiment, high 
titer of IgG that targeted Myt272 protein was 
detected by the optical density (OD) in mice 
injected with Myt272 recombinant protein 
from the partially purified lysate emulsified in 
Ribi adjuvant. The T-test showed that Myt272 
protein antigen emulsified in Ribi adjuvant 
had stimulated an extremely statistically 
significant high level of IgG with respect to 
the control groups with p < 0.05. This high 
titer may indicate that this vaccination can 
induce a specific humoral response in the 
host [Error! Bookmark not defined.]. The 
control groups were pooled together as one 
group because the T-test showed that there 
was no significant difference between the 
ODs among the control groups with p > 0.05. 
The partially purified lysate should contain 
mainly the recombinant protein (IDALA) as 
we have obtained positive results of two 
bands for the double digestion of 
pUC18/Myt272 and pQE32/Myt272 vector 
systems indicating a nucleotide size of 448 
bp for Myt272 insert (Fig 2). Surprisingly, 
recombinant protein only without Ribi 
adjuvant was not able to induce 
immunogenicity in mice may be due to failure 
of drug delivery [21]. IDALA protein had 
shown high immunogenic activity in the 
immunized mice compared to controls (Fig 
4), hence this protein is proposed as a 
potential vaccine candidate. Unfortunately, in 
this study, we were not able to purify the His-
tagged recombinant protein due to poor 
resolution of SDS-PAGE gel electrophoresis. 
Hence, more works are required to further 
purify and characterize this protein, in 




In conclusion, Myt272 gene showed high 
identity with Mycobacterium tuberculosis 
H37Rv unknown hypothetical protein from 
Rv3424c gene. The protein blasts indicated 
that a 10.1 kD IDALA protein could be the 
potential peptide vaccine for tuberculosis 
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